Darren B Dressen

This inventor holds 38 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Leukocyte Adhesion Inhibitors. Top assignees: Elan Pharmaceuticals, Inc., Wyeth, Other. Active years: 2002-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darren B Dressen. Retrieved from https://idiyas.com/inventor/darren-b-dressen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 1)

% Patents Active = 34.2

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 9.2

ph-index = 10

Forward Citations = 322(Granted Patents)

Location History:

San Mateo, CA (US) (2002 - 2009)
San Francisco, CA (US) (2004 - 2011)
Fremont, CA (US) (2010 - 2012)

Company Filing History:

24 out of 202

Elan Pharmaceuticals, Inc.

13 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2012

Loading Chart...

Areas of Expertise:

Leukocyte Adhesion

VLA-4 Inhibitors

Phenylalanine Derivatives

Alpha Amino Acid Derivatives

Hydroxyethylamine

Dipeptides

Carbamyloxy Compounds

Pyrazolopyrrolidines

Heteroaryl Compounds

Beta-Amino Acid Derivatives

Acylated Amino Acids

Substituted Compounds

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8283358 - N-sulfonamido polycyclic pyrazolyl compounds (2012-10-09),

2. 7977368 - Pyrazolopyrrolidines as inhibitors of gamma secretase (2011-07-12),

3. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),

4. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),

5. 7858642 - Substituted hydroxyethylamine aspartyl protease inhibitors (2010-12-28),

6. 7759382 - Acylated amino acid amidyl pyrazoles and related compounds (2010-07-20),

7. 7745454 - Alpha amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2010-06-29),

8. 7576101 - Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents (2009-08-18),

9. 7432379 - [object Object] (2008-10-07),

10. 7417152 - [object Object] (2008-08-26),

11. 7378529 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-05-27),

12. 7365073 - 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2008-04-29),

13. 7320960 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-01-22),

14. 7291645 - Phenylalanine derivatives as alpha 4 integrin inhibitors (2007-11-06),

15. 7288526 - Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-10-30),

Title: Innovations and Contributions of Darren B. Dressen in Cognitive Disorder Treatments

Introduction

Darren B. Dressen, based in San Mateo, CA, is a notable inventor with a remarkable portfolio of 38 patents. His work primarily focuses on innovative solutions for cognitive disorders, particularly diseases like Alzheimer's. With a wealth of experience in the pharmaceutical industry, Dressen has made significant strides in developing compounds that address these critical health challenges.

Latest Patents

Dressen's latest patents showcase his dedication and ingenuity in the field of pharmacology. One of his recent inventions includes N-sulfonamido polycyclic pyrazolyl compounds, which are structured according to specific formulae that target cognitive disorders. This invention not only provides pharmaceutical compositions containing these compounds but also outlines methods for their use in treating disorders like Alzheimer's disease.

Another significant patent involves pyrazolopyrrolidines as inhibitors of gamma secretase. This invention emphasizes the utility of specific compounds in preventing and treating cognitive disorders. It includes details about pharmaceutical compositions, preparation methods, and therapeutic applications, particularly relating to Alzheimer's disease as well.

Career Highlights

Darren B. Dressen has had an impactful career, having worked with notable companies in the pharmaceutical sector, including Elan Pharmaceuticals, Inc. and Wyeth. His insights and innovations have been instrumental in advancing research focused on cognitive health.

Collaborations

Throughout his career, Dressen has collaborated with esteemed colleagues such as Michael A. Pleiss and Eugene D. Thorsett. These partnerships have further enriched his work and have contributed to the development of effective treatments for cognitive disorders.

Conclusion

Darren B. Dressen's contributions to the field of cognitive disorders through his numerous patents exemplify his commitment to innovation and improving health outcomes. His work in developing therapeutic compounds offers hope for many individuals affected by Alzheimer's disease and sets a precedent for future research in this important area.

Profile summary based on public USPTO records.